Cargando…
On-site Availability Improves Vaccination Rates in Patients With Inflammatory Bowel Disease
Autores principales: | Hashash, Jana G, Farraye, Francis A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802186/ https://www.ncbi.nlm.nih.gov/pubmed/36777281 http://dx.doi.org/10.1093/crocol/otab068 |
Ejemplares similares
-
Health Maintenance for Adult Patients with Inflammatory Bowel Disease
por: Hashash, Jana G., et al.
Publicado: (2021) -
Efficacy of Paxlovid and Lagevrio for COVID-19 Infection in Patients With Inflammatory Bowel Disease: A Propensity-Matched Study
por: Hashash, Jana G., et al.
Publicado: (2023) -
Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
por: Desai, Aakash, et al.
Publicado: (2023) -
Association of serum IgG4 and disease outcomes in patients with inflammatory bowel disease
por: Chase, R. Christopher, et al.
Publicado: (2023) -
A Cohort Study of the Age at Menopause in Female Patients With and Without Inflammatory Bowel Disease
por: Moktan, Varun P, et al.
Publicado: (2022)